Abstract
The dialysis encephalopathy syndrome (DES) consists of altered mental status, communication difficulty, seizures and myoclonus. It has been attributed to elevated serum aluminium (A1) levels. Two undialysed patients with chronic renal failure who presented with the characteristic syndrome are reported. The first, a 48 year old female, had used A1 containing phosphate binders for two years. Her serum A1 level was 25.34 mumol/L. Despite treatment with desferoximine and dialysis, she died. Necropsy revealed elevated A1 levels in the cerebral cortex (19 mcg/gm) and spongioform change in the outer three cortical layers. The second patient, a 46 year old woman, had a serum A1 of 8.70 mumol/L. She had never taken A1 containing phosphate binders but had taken several grams/day of citrate for at least six months. Treatment with haemodialysis and discontinuation of the citrate produced a resolution of symptoms and return of the A1 level to normal. During two years of haemodialysis there has been no recurrence.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alfrey A. C., Hegg A., Craswell P. Metabolism and toxicity of aluminum in renal failure. Am J Clin Nutr. 1980 Jul;33(7):1509–1516. doi: 10.1093/ajcn/33.7.1509. [DOI] [PubMed] [Google Scholar]
- Alfrey A. C., LeGendre G. R., Kaehny W. D. The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med. 1976 Jan 22;294(4):184–188. doi: 10.1056/NEJM197601222940402. [DOI] [PubMed] [Google Scholar]
- Alfrey A. C., Mishell J. M., Burks J., Contiguglia S. R., Rudolph H., Lewin E., Holmes J. H. Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans Am Soc Artif Intern Organs. 1972;18(0):257-61, 266-7. doi: 10.1097/00002480-197201000-00064. [DOI] [PubMed] [Google Scholar]
- Bakir A. A., Hryhorczuk D. O., Berman E., Dunea G. Acute fatal hyperaluminemic encephalopathy in undialyzed and recently dialyzed uremic patients. ASAIO Trans. 1986 Jul-Sep;32(1):171–176. [PubMed] [Google Scholar]
- Berlyne G. M., Ben-Ari J., Pest D., Weinberger J., Stern M., Levine R., Gilmore G. R. Hyperaluminaemia from aluminum resins in renal failure. Lancet. 1970 Sep 5;2(7671):494–496. doi: 10.1016/s0140-6736(70)90113-3. [DOI] [PubMed] [Google Scholar]
- Boegman R. J., Bates L. A. Neurotoxicity of aluminum. Can J Physiol Pharmacol. 1984 Aug;62(8):1010–1014. doi: 10.1139/y84-170. [DOI] [PubMed] [Google Scholar]
- Crapper D. R., Krishnan S. S., Quittkat S. Aluminium, neurofibrillary degeneration and Alzheimer's disease. Brain. 1976 Mar;99(1):67–80. doi: 10.1093/brain/99.1.67. [DOI] [PubMed] [Google Scholar]
- Kaehny W. D., Hegg A. P., Alfrey A. C. Gastrointestinal absorption of aluminum from aluminum-containing antacids. N Engl J Med. 1977 Jun 16;296(24):1389–1390. doi: 10.1056/NEJM197706162962407. [DOI] [PubMed] [Google Scholar]
- Marsden S. N., Parkinson I. S., Ward M. K., Ellis H. A., Kerr D. N. Evidence for aluminium accumulation in renal failure. Proc Eur Dial Transplant Assoc. 1979;16:588–596. [PubMed] [Google Scholar]
- McDermott J. R., Smith A. I., Ward M. K., Parkinson I. S., Kerr D. N. Brain-aluminium concentration in dialysis encephalopathy. Lancet. 1978 Apr 29;1(8070):901–904. doi: 10.1016/s0140-6736(78)90681-5. [DOI] [PubMed] [Google Scholar]
- Sherrard D. J. Aluminum--much ado about something. N Engl J Med. 1991 Feb 21;324(8):558–559. doi: 10.1056/NEJM199102213240810. [DOI] [PubMed] [Google Scholar]
- Winkelman M. D., Ricanati E. S. Dialysis encephalopathy: neuropathologic aspects. Hum Pathol. 1986 Aug;17(8):823–833. doi: 10.1016/s0046-8177(86)80203-9. [DOI] [PubMed] [Google Scholar]